ArticleFrontiers in oncology2023

Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis.

Samuel A Kareff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.